首页|环形RNA翻译及其在药物研发中的应用

环形RNA翻译及其在药物研发中的应用

扫码查看
以新冠mRNA疫苗为代表的mRNA药物在新冠疫情中发挥重要的作用.而在后疫情时代,mRNA技术的应用范围不断被扩展.环形RNA比线性mRNA有更高的稳定性,有望提供比mRNA更大的治疗窗口,因此作为新一代的mRNA药物平台有广泛应用前景.同时环形RNA的设计与生产、载体选择与制备以及递送选择等方面,也有很多技术特色和挑战.本文对于环形RNA的体内外合成、翻译调控以及递送和应用各方面进行简要的总结和讨论.期望对关心环形RNA技术应用的读者有所参考和启发.未来研究中,环形RNA技术将向着提高表达和递送效率,以及降低其天然免疫原性的方向来进行优化.
Circular RNA translation and its application in drug development
mRNA vaccine has played an important role in the COVID-19 epidemic,which marks the beginning of mRNA therapy.In the post-pandemic era,the application of mRNA therapy continues to expand.With a higher stability and lower innate immunogenicity,the circular RNAs(circRNAs)are expected to provide a larger therapeutic window than mRNA.Therefore,it has potential to serve as a new platform technology for the next generation of mRNA therapy.Meanwhile,there are many technical features and challenges in the target selection,sequence design,production and delivery of circRNA drugs.This review briefly summarizes and discusses various aspects of circRNAs as potential therapeutic,including the synthesis,translational regulation,delivery and application.We aim to provide brief introduction to readers who are concerned about the application of circular RNA technology.We also discussed the future of circular RNA technology,which will be improved towards a higher expression efficiency,higher delivery efficiency and lower innate immunogenicity.

mRNA therapycircular RNAnon-canonical translationRNA delivery

茅缪伟、张喆宇、魏言欢、王泽峰

展开 >

中国科学院上海免疫与感染研究所,上海 200031

中国科学院上海营养与健康研究所,上海 200031

南方科技大学生命科学学院,深圳 518055

mRNA疗法 环形RNA 非经典翻译 RNA递送

国家重点研发计划"生物大分子与微生物组"重点专项

2021YFA1300503

2024

中国科学(生命科学)
中国科学院

中国科学(生命科学)

CSTPCD北大核心
影响因子:0.725
ISSN:1674-7232
年,卷(期):2024.54(4)
  • 107